277 related articles for article (PubMed ID: 31727006)
1. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract][Full Text] [Related]
2. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
[TBL] [Abstract][Full Text] [Related]
3. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
4. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
[TBL] [Abstract][Full Text] [Related]
5. EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.
Mahmud Z; Gomes AR; Lee HJ; Aimjongjun S; Jiramongkol Y; Yao S; Zona S; Alasiri G; Gong G; Yagüe E; Lam EW
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31357743
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.
Li D; Ye L; Lei Y; Wan J; Chen H
BMB Rep; 2019 Mar; 52(3):208-213. PubMed ID: 30638177
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.
Liu L; Huang P; Wang Z; Chen N; Tang C; Lin Z; Peng P
BMC Cancer; 2016 Oct; 16(1):813. PubMed ID: 27756261
[TBL] [Abstract][Full Text] [Related]
8. Asiatic Acid, Extracted from
Liu YT; Chuang YC; Lo YS; Lin CC; Hsi YT; Hsieh MJ; Chen MK
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31991751
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival.
Alasiri G; Jiramongkol Y; Trakansuebkul S; Ke HL; Mahmud Z; Intuyod K; Lam EW
Mol Cell Endocrinol; 2020 Sep; 515():110932. PubMed ID: 32615282
[TBL] [Abstract][Full Text] [Related]
10. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
11. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells.
Liang R; Rimmelé P; Bigarella CL; Yalcin S; Ghaffari S
Cell Cycle; 2016; 15(6):861-7. PubMed ID: 26929388
[TBL] [Abstract][Full Text] [Related]
12. Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells.
Alasiri G; Jiramongkol Y; Zona S; Fan LY; Mahmud Z; Gong G; Lee HJ; Lam EW
Oncogene; 2019 Sep; 38(36):6382-6398. PubMed ID: 31312024
[TBL] [Abstract][Full Text] [Related]
13. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
14. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway.
Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma.
Chiang C; Zhang M; Wang D; Xiao T; Zhu L; Chen K; Huang J; Huang J; Zhu J; Li L; Chen C; Chen Y; Hu H; Jiang W; Zou Y; Wang T; Zheng D
Theranostics; 2020; 10(17):7906-7920. PubMed ID: 32685028
[No Abstract] [Full Text] [Related]
16. SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.
Khongkow M; Olmos Y; Gong C; Gomes AR; Monteiro LJ; Yagüe E; Cavaco TB; Khongkow P; Man EP; Laohasinnarong S; Koo CY; Harada-Shoji N; Tsang JW; Coombes RC; Schwer B; Khoo US; Lam EW
Carcinogenesis; 2013 Jul; 34(7):1476-86. PubMed ID: 23514751
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
Feng Q; He P; Wang Y
Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
[TBL] [Abstract][Full Text] [Related]
18. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
[TBL] [Abstract][Full Text] [Related]
19. [Research of SIRT1 on promoting the proliferation, migration and lipid metabolism of nasopharyngeal carcinoma].
Yin HM; He X; Shan Y; Zhai HX; Zhang KW; Xia T; Zhang SY; Chen WH; You YW
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):934-943. PubMed ID: 33036508
[No Abstract] [Full Text] [Related]
20. SIRT2 regulates oxidative stress-induced cell death through deacetylation of c-Jun NH
Sarikhani M; Mishra S; Desingu PA; Kotyada C; Wolfgeher D; Gupta MP; Singh M; Sundaresan NR
Cell Death Differ; 2018 Sep; 25(9):1638-1656. PubMed ID: 29449643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
